Results 231 to 240 of about 1,333,689 (304)
Changing the Face of Medicine Library Programs, Vol.21 (4) April - June 2008 [PDF]
Houston Academy of Medicine-Texas Medical Center Library
core +1 more source
ABSTRACT Accumulating evidence suggests that the intestinal microbiota participates in the progression of metabolic dysfunction‐associated steatotic liver disease (MASLD) through microbiota‐host interaction. However, the beneficial role of commensal mycobiota in MASLD progression remains poorly understood.
Shuping Qiao +11 more
wiley +1 more source
NPM1 selectively sorts specific mRNAs into extracellular vesicles (EVs) by recognizing RNA motifs and forming phase‐separated condensates. These mRNA cargos—including EGFR—are then loaded via multivesicular bodies. This active sorting pathway, validated in EVs derived from both lung cancer cells and patient serum, reveals a specific mechanism for ...
Kaixiang Zhang +8 more
wiley +1 more source
Neuid: A Novel Neuron‐Enriched LncRNA that Connects Epigenetic Gene Silencing to Alzheimer's Disease
ABSTRACT The increasing evidence that non‐coding RNAs can become deregulated during pathogenesis is dramatically expanding the space for drug discovery beyond the protein‐coding genome. Long noncoding RNAs (lncRNAs) are emerging as key regulators of cellular function, yet most remain uncharacterized.
Ranjit Pradhan +17 more
wiley +1 more source
Efficacy and safety of opioid-receptor antagonists for opioid-induced constipation: a systematic review and meta-analysis. [PDF]
Li Y +9 more
europepmc +1 more source
NNLM\SCR Contract Awarded, Vol.14 (4) July - August 2001 [PDF]
Houston Academy of Medicine-Texas Medical Center Library
core +1 more source
Protein restriction (PR) slows Alzheimer's disease (AD) in mice, and other benefits of PR are due to decreased branched‐chain amino acids (BCAAs). We show that restricting any BCAA has benefits, with sex‐ and BCAA‐specific impacts on pathology, molecular signaling, and cognition.
Reji Babygirija +22 more
wiley +1 more source
8th Annual HAM-TMC Library Conference, Vol.2 (3) May - June 2004 [PDF]
Houston Academy of Medicine-Texas Medical Center Library
core +1 more source
This study presents the de novo design and directed evolution of a mirror‐image D‐protein inhibitor targeting human interleukin‐4 (IL‐4). The engineered molecule exhibits nanomolar binding affinity for IL‐4 and effectively inhibits IL‐4–mediated signaling.
Liqing Xu +7 more
wiley +1 more source
Fund Raising, Vol.21 (2) October - December 2007 [PDF]
Houston Academy of Medicine-Texas Medical Center Library
core +1 more source

